Isamu Sugiura Selected Research

Isamu Sugiura Research Topics

Disease

12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 12/2004
12	Philadelphia Chromosome 02/2024 - 08/2007
9	Multiple Myeloma 07/2022 - 05/2009
8	Leukemia 02/2024 - 09/2004
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 10/2007
5	Lymphoma (Lymphomas) 01/2023 - 01/2017
4	Residual Neoplasm 11/2023 - 09/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 09/2015
2	Infections 01/2024 - 09/2015
2	Pathologic Complete Response 09/2008 - 01/2006
1	Febrile Neutropenia 01/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2021
1	Hairy Cell Leukemia 02/2021
1	Hypoprothrombinemias (Prothrombin Deficiency) 01/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Hyperglycemia 03/2017
1	Colitis 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2016
1	Hepatitis 09/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015
1	Hematoma 06/2015
1	Paralysis (Palsy) 06/2015
1	Pain (Aches) 06/2015
1	Brain Infarction 06/2015
1	Stroke (Strokes) 06/2015
1	Hypesthesia (Numbness) 06/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2008
1	Acute Promyelocytic Leukemia 03/2008
1	Lymphadenopathy 01/2006
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2006
1	Lymphocytosis 01/2006

Drug/Important Bio-Agent (IBA)

10	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 12/2004
5	Dexamethasone (Maxidex)FDA LinkGeneric 07/2022 - 10/2015
5	Rituximab (Mabthera)FDA Link 05/2022 - 03/2012
3	Tyrosine Kinase InhibitorsIBA 02/2024 - 12/2017
3	Lenalidomide (CC 5013)FDA Link 07/2022 - 03/2017
3	carfilzomibIBA 02/2021 - 03/2017
2	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2016
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 10/2015
2	Etoposide (VP 16)FDA LinkGeneric 03/2021 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2020 - 09/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2015
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 09/2004
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2020 - 09/2015
2	AntibodiesIBA 01/2020 - 09/2015
2	plerixafor FDA Link 11/2018 - 11/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017 - 10/2007
2	Bortezomib (Velcade)FDA Link 01/2016 - 10/2015
2	Phosphotransferases (Kinase)IBA 05/2011 - 10/2010
1	quizartinibIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	daratumumabIBA 07/2022
1	pomalidomideIBA 07/2022
1	Methotrexate (Mexate)FDA LinkGeneric 05/2022
1	Vincristine (Oncovin)FDA LinkGeneric 05/2022
1	Procarbazine (Matulane)FDA Link 05/2022
1	Clofarabine (Clolar)FDA Link 03/2021
1	Bendamustine Hydrochloride FDA Link 02/2021
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2020
1	Azacitidine (5 Azacytidine)FDA Link 02/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2015
1	SteroidsIBA 09/2015
1	Hepatitis B Core AntigensIBA 09/2015
1	AnticoagulantsIBA 06/2015
1	Thalidomide (Thalomid)FDA Link 06/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2008
1	Inosine Triphosphate (ITP)IBA 04/2008
1	AnthracyclinesIBA 10/2007
1	Complementary DNA (cDNA)IBA 08/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2006
1	AutoantibodiesIBA 01/2006

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2023 - 12/2004
11	Therapeutics 01/2024 - 01/2006
5	Hematopoietic Stem Cell Transplantation 05/2023 - 12/2004
3	Stem Cell Transplantation 02/2024 - 05/2009
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 05/2023 - 03/2010
2	Autologous Transplantation 11/2018 - 11/2018
1	Consolidation Chemotherapy 01/2024
1	Terminal Care (Care, Terminal) 01/2023
1	Radiotherapy 05/2022
1	EC regimen 01/2017
1	Blood Component Removal (Apheresis) 06/2015
1	Laminectomy 06/2015
1	Transplantation 03/2008
1	Induction Chemotherapy 10/2007
1	Remission Induction 01/2006